F. De Vloed

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

F. Speleman, M. Fischer, R. Versteeg, 2023, Nature Communications.

HTSplotter: An end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening

F. Speleman, J. Vandesompele, V. Vermeirssen, 2021, bioRxiv.

SOX11 is a lineage-dependency factor and master epigenetic regulator in neuroblastoma

F. Speleman, M. Fischer, R. Versteeg, 2020, bioRxiv.

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

F. Speleman, M. Fischer, J. Houseley, 2022, Science advances.

RRM2 is a target for synthetic lethal interactions with replication stress checkpoint addiction in high-risk neuroblastoma

F. Speleman, M. Fischer, D. Deforce, 2020, bioRxiv.

Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma.

S. van Calenbergh, J. Molenaar, B. de Wilde, 2022, European journal of medicinal chemistry.

Measurable impact of RNA quality on gene expression results from quantitative PCR

F. Speleman, J. Vandesompele, J. Hellemans, 2011, Nucleic acids research.